As of May 28, 2025, Biopower Operations Corp has a Discounted Cash Flow (DCF) derived fair value of $0.00 per share. With the current market price at $0.00, this represents a potential upside of -583587.6%.
| Key Metrics | Value |
|---|---|
| DCF Fair Value (5-year) | $0.00 |
| DCF Fair Value (10-year) | $0.00 |
| Potential Upside (5-year) | -583072.2% |
| Potential Upside (10-year) | -583587.6% |
| Discount Rate (WACC) | 3.8% - 5.0% |
Revenue is projected to grow from $1 million in 11-2022 to $1 million by 11-2032, representing a compound annual growth rate of approximately 0.0%.
| Fiscal Year | Revenue (USD millions) | Growth |
|---|---|---|
| 11-2022 | 1 | 227% |
| 11-2023 | 1 | 6% |
| 11-2024 | 1 | 3% |
| 11-2025 | 1 | 2% |
| 11-2026 | 1 | 2% |
| 11-2027 | 1 | 2% |
| 11-2028 | 1 | 3% |
| 11-2029 | 1 | 6% |
| 11-2030 | 1 | 5% |
| 11-2031 | 1 | 2% |
| 11-2032 | 1 | 2% |
Net profit margin is expected to improve from -139% in 11-2022 to -80% by 11-2032, driven by operational efficiency and economies of scale.
| Fiscal Year | Net Profit (USD millions) | Profit Margin |
|---|---|---|
| 11-2022 | (1) | -139% |
| 11-2023 | (1) | -61% |
| 11-2024 | (1) | -63% |
| 11-2025 | (1) | -64% |
| 11-2026 | (1) | -66% |
| 11-2027 | (1) | -67% |
| 11-2028 | (1) | -69% |
| 11-2029 | (1) | -73% |
| 11-2030 | (1) | -77% |
| 11-2031 | (1) | -79% |
| 11-2032 | (1) | -80% |
with a 5-year average of $0 million. Projected CapEx is expected to maintain at approximately 22% of revenue.
Depreciation is based on an average useful life of 5 years for capital assets.
| Fiscal Year | D&A (USD millions) |
|---|---|
| 11-2023 | 0 |
| 11-2024 | 0 |
| 11-2025 | 0 |
| 11-2026 | 0 |
| 11-2027 | 0 |
| 11-2028 | 0 |
Net working capital is expected to increase gradually, with projected changes affecting free cash flow.
| Components | Average Days |
|---|---|
| Days Receivables | 0 |
| Days Inventory | 0 |
| Days Payables | 0 |
| Fiscal Year | EBITDA | Tax | CapEx | Change in NWC | FCF |
|---|---|---|---|---|---|
| 6M/2023 | (0) | (0) | 0 | (0) | (0) |
| 2024 | (1) | (0) | 0 | 0 | (1) |
| 2025 | (1) | (0) | 0 | 0 | (0) |
| 2026 | (1) | (0) | 0 | (0) | (0) |
| 2027 | (1) | (0) | 0 | 0 | (0) |
| Valuation Method | Fair Price (USD) | Potential Upside |
|---|---|---|
| 5-Year DCF (Growth) | 0.00 | -583072.2% |
| 10-Year DCF (Growth) | 0.00 | -583587.6% |
| 5-Year DCF (EBITDA) | 0.00 | NaN% |
| 10-Year DCF (EBITDA) | 0.00 | NaN% |
Is Biopower Operations Corp (BOPO) a buy or a sell? Biopower Operations Corp is definitely a sell. Based on our DCF analysis, Biopower Operations Corp (BOPO) appears to be overvalued with upside potential of -583587.6%. The company's strong projected growth in revenue and profitability, coupled with consistent capital expenditure, supports our positive outlook on its intrinsic value.
Key investment drivers include:
Investors should consider reducing exposure at the current market price of $0.00.